Pharvaris NV
F:9EN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharvaris NV
F:9EN
|
NL |
|
Fisher & Paykel Healthcare Corporation Ltd
F:FPLB
|
NZ |
|
B
|
BP PLC
F:BSU
|
UK |
|
Orkla ASA
OSE:ORK
|
NO |
|
Wacul Inc
TSE:4173
|
JP |
|
D
|
Doxa AB
STO:DOXA
|
SE |
|
A
|
Accor SA
F:ACR
|
FR |
|
Saga Pure ASA
F:SAT
|
NO |
|
S
|
Smith & Nephew PLC
DUS:NPW1
|
UK |
|
D
|
DENTSPLY SIRONA Inc
SWB:DY2
|
US |
|
Y
|
Yankuang Energy Group Co Ltd
XMUN:YZCA
|
CN |
|
Bharat Electronics Ltd
BSE:500049
|
IN |
|
S
|
Sega Sammy Holdings Inc
XMUN:RYU
|
JP |
|
D
|
DENTSPLY SIRONA Inc
XBER:DY2
|
US |
|
D
|
DoorDash Inc
NASDAQ:DASH
|
US |
|
U
|
Upstart Holdings Inc
F:855
|
US |
Wall St Price Targets
9EN Price Targets Summary
Pharvaris NV
According to Wall Street analysts, the average 1-year price target for
9EN is 26.22 EUR with a low forecast of 20.21 EUR and a high forecast of 41.48 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9EN's stock price target?
Price Target
26.22
EUR
According to Wall Street analysts, the average 1-year price target for
9EN is 26.22 EUR with a low forecast of 20.21 EUR and a high forecast of 41.48 EUR.